Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis.
Saved in:
| Title: | Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis. |
|---|---|
| Authors: | Mohammed S; Stephenson Cancer Center, Oklahoma City, Oklahoma.; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Thadathil N; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Ohene-Marfo P; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Tran AL; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Van Der Veldt M; Genes and Human Disease Research Program, Oklahoma City, Oklahoma., Georgescu C; Genes and Human Disease Research Program, Oklahoma City, Oklahoma., Oh S; Stephenson Cancer Center, Oklahoma City, Oklahoma.; Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Nicklas EH; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Wang D; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Haritha NH; Stephenson Cancer Center, Oklahoma City, Oklahoma.; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Luo W; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Janknecht R; Stephenson Cancer Center, Oklahoma City, Oklahoma.; Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Miller BF; Oklahoma Center for Geroscience & Brain Aging, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.; Oklahoma City VA medical Center, Oklahoma City, Oklahoma., Wren JD; Genes and Human Disease Research Program, Oklahoma City, Oklahoma., Freeman WM; Genes and Human Disease Research Program, Oklahoma City, Oklahoma.; Oklahoma Center for Geroscience & Brain Aging, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Oklahoma City VA medical Center, Oklahoma City, Oklahoma., Deepa SS; Stephenson Cancer Center, Oklahoma City, Oklahoma.; Department of Biochemistry & Molecular Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Oklahoma Center for Geroscience & Brain Aging, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Oklahoma City VA medical Center, Oklahoma City, Oklahoma. |
| Source: | Molecular cancer research : MCR [Mol Cancer Res] 2023 Sep 01; Vol. 21 (9), pp. 933-946. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
